Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years
- PMID: 19685532
- DOI: 10.1002/cncr.24624
Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years
Abstract
Background: Studies have shown that follow-up care for cancer patients differs by physician specialty, and that coordination between specialists and generalists results in better care. Little is known, however, regarding which specialties of physicians provide care to long-term cancer survivors.
Methods: The authors used Surveillance, Epidemiology, and End Results data from 1992 through 1997 that were linked to 1997-2003 Medicare data to identify persons diagnosed >5 years earlier with bladder, female breast, colorectal, prostate, or uterine cancer. Physician specialties were assigned by combining Medicare data with the American Medical Association Masterfile and the Unique Physician Identification Number Registry. The percentage of long-term survivors who visited physicians of interest was determined by analyzing Medicare outpatient claims submitted 6 to 12 years after initial diagnosis.
Results: Over the entire study period, 46% of female breast cancer survivors, 26% of colorectal cancer survivors, and 14% of prostate cancer survivors saw hematologists/oncologists. Radiation oncologists were seen by 11%, 2%, and 14% of breast, colorectal, and prostate cancer survivors, respectively. Survivors also sought care from specialists related to their cancer: 19% of breast cancer survivors had a cancer-coded visit with a surgeon, 26% of colorectal cancer survivors visited a gastroenterologist, and 68% of prostate cancer survivors visited a urologist. The percentage of survivors who visited cancer and cancer-related physicians declined each year. In contrast, nearly 75% of female breast, colorectal, and prostate cancer survivors saw primary care providers, and these percentages did not decrease annually.
Conclusions: The findings of the current study underscore the need to include both primary care providers and cancer-related specialists in education and guidelines regarding cancer survivorship.
Similar articles
-
Preventive care for colorectal cancer survivors: a 5-year longitudinal study.J Clin Oncol. 2008 Mar 1;26(7):1073-9. doi: 10.1200/JCO.2007.11.9859. J Clin Oncol. 2008. PMID: 18309941
-
American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors.Cancer. 2010 May 1;116(9):2090-8. doi: 10.1002/cncr.25038. Cancer. 2010. PMID: 20198707
-
Surveillance testing among survivors of early-stage breast cancer.J Clin Oncol. 2007 Mar 20;25(9):1074-81. doi: 10.1200/JCO.2006.08.6876. J Clin Oncol. 2007. PMID: 17369571
-
Survivorship: adult cancer survivors.Prim Care. 2009 Dec;36(4):721-41. doi: 10.1016/j.pop.2009.08.001. Prim Care. 2009. PMID: 19913184 Review.
-
Monitoring the physical health of cancer survivors: a survivorship-focused medical history.J Clin Oncol. 2006 Nov 10;24(32):5105-11. doi: 10.1200/JCO.2006.06.0541. J Clin Oncol. 2006. PMID: 17093271 Review.
Cited by
-
Primary Care Provider Involvement in Thyroid Cancer Survivorship Care.J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3300-6. doi: 10.1210/clinem/dgaa437. J Clin Endocrinol Metab. 2020. PMID: 32639557 Free PMC article.
-
Oncology and Primary Care Provider Views on Cancer Survivorship Care: Mind the Gap.J Am Board Fam Med. 2022 Mar-Apr;35(2):329-340. doi: 10.3122/jabfm.2022.02.210286. J Am Board Fam Med. 2022. PMID: 35379720 Free PMC article.
-
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.Ecancermedicalscience. 2016 Jan 5;10:608. doi: 10.3332/ecancer.2016.608. eCollection 2016. Ecancermedicalscience. 2016. PMID: 26913066 Free PMC article.
-
Survivorship care plans and time since diagnosis: factors that contribute to who breast cancer survivors see for the majority of their care.Support Care Cancer. 2015 Sep;23(9):2669-76. doi: 10.1007/s00520-015-2629-5. Epub 2015 Feb 10. Support Care Cancer. 2015. PMID: 25663574
-
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.Curr Hematol Malig Rep. 2016 Aug;11(4):271-9. doi: 10.1007/s11899-016-0331-4. Curr Hematol Malig Rep. 2016. PMID: 27177742 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical